Adding interventions to interferon in chronic HCV infections.
نویسندگان
چکیده
منابع مشابه
Adding interventions to interferon in chronic HCV infections.
Interferon alfa is the only licensed therapy for chronic hepatitis C. The response rate with interferon monotherapy in terms of sustained loss ofHCV RNA is 20-25%. It is now possible to predict, from baseline host and viral factors and from the early response to interferon, which patients are most likely to respond to therapy.' Patients with cirrhosis or type lb infection, for example, are less...
متن کاملCirculating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
The IFN-λ3 gene (IFNL3) plays a role in HCV clearance. We investigated circulating IFN-λ3 and IFNL3 SNPs in haemodialysis patients who differed in their response to HBV vaccination and their HBV/HCV infection status. In 201 patients, plasma IFN-λ3 was determined using ELISA. IFNL3 SNPs (rs12979860, rs8099917) were genotyped using HRM analysis. Differences in IFN-λ3 levels were shown between res...
متن کاملHCV cure without interferon
The launch of first-generation protease inhibitors (PIs) was a major step forward in HCV treatment. However, this major advance was restricted to genotype 1 (GT-1) patients. This year the launch of Sofosbuvir a NS5B nucleotide inhibitor (Nis), Daclatasvir a NS5A inhibitor (NS5A.I) and Simeprevir a second wave PIs open new perspective for IFN-free regimen. Both Sofosbuvir and Daclatasvir have a ...
متن کاملSerum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections.
1. Leeder SR, Rychetnik L. Ethics and evidence-based medicine. Med J Aust 2001; 175: 161-164. 2. Sackett DL, Rosenberg WM, Gray JA, et al. Evidencebased medicine: what it is and what it isn’t. BMJ 1996; 312: 71-72. 3. Mathers CD, Vos ET, Stevenson CE, Begg SJ. The Australian burden of disease study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust 2000; 172: 592...
متن کاملInterferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
In chronic HCV infection, treatment failure and defective host immune response highly demand improved therapy strategies. Vγ9Vδ2 T-cells may inhibit HCV replication in vitro through IFN-γ release after Phosphoantigen (PhAg) stimulation. The aim of our work was to analyze Vγ9Vδ2 T-cell functionality during chronic HCV infection, studying the role of IFN-α on their function capability. IFN-γ prod...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 1996
ISSN: 0017-5749
DOI: 10.1136/gut.39.5.769